Promise of TROP2 ADCs: AstraZeneca, Daiichi Sankyo’s $6bn collaboration

This latest deal for DS-1062 represents AstraZeneca and Daiichi Sankyo’s second ADC partnership. Credit: Sarahkayb via Wikimedia.



  • AstraZeneca Daiichi ADC